Eurofins expands its environment testing footprint in the US with the acquisition of Calscience Environmental Laboratories

Eurofins Scientific (EUFI.PA), the world leader in environmental laboratory services, announces that it has signed an agreement to acquire Calscience Environmental Laboratories, Inc. (Calscience) in the US. The transaction is expected to close no later than the 31^st of May.

Founded in 1986, Calscience is an industry leader in the environmental and marine chemistry testing field and has grown to become the largest independent full-service environmental testing laboratory on the West Coast. Generating revenues of over US $20m and employing 180 staff, Calscience operates a 60,000-square foot state-of-the-art laboratory in Garden Grove, California, and service centers throughout California and Texas.

With a strong industry reputation for quality and customer focus, Calscience offers a comprehensive range of analytical methods with expertise encompassing all environmental matrices, including, air, groundwater, marine, sediment, soil, solid waste, and wastewater. Calscience serves a diverse range of clients, including Fortune 100 Companies, the environmental engineering community, consultants, private industry and federal, state, and local governments. Calscience holds accreditations, including National Environmental Laboratory Accreditation Program (NELAP) and Environmental Laboratory Accreditation Program (ELAP), the US Department of Defense Environmental Laboratory Accreditation Program (DoD-ELAP), as well as state agencies throughout theUnited States.

Comment from Dr. Gilles Martin, Eurofins CEO: "The addition of Calscience into Eurofins' growing portfolio of Centers for Excellence in environmental testing in the US strengthens the Group's position as the industry's premier provider of analytical testing services. By sharing best practices, clients will benefit from an unparalleled spectrum of quality testing services, data access and capacity from coast to coast, which in turn should fuel further market share growth for the Group."

For more information, please visit www.eurofins.com or contact:

About Eurofins Scientific

Eurofins - a global leader in bio-analysis

Eurofins Scientific is the world leader in food and pharmaceutical products testing. It is also number one in the world in the field of environmental laboratory services and one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services.

With about 15,000 staff in more than 190 laboratories across 36 countries, Eurofins offers a portfolio of over 100,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.

Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.

As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.

The shares of Eurofins Scientific are listed on the NYSE Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).

Important disclaimer:

This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgement of Eurofins Scientific’ management as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the information available to the Company’s management as of the date of publication, but no guarantee can be made as to their validity.